Thomas Doyle

Insider Reports History

Entity
Individual
Location
C/O Kura Oncology, Inc., 12730 High Bluff Drive, Suite 400, San Diego, CA
Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Doyle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kura Oncology, Inc. SVP, Finance & Accounting Common Stock 93.1K $1.49M $16.03 Jan 2, 2025 Direct
Kura Oncology, Inc. SVP, Finance & Accounting Common Stock 500 $8.02K $16.03 Jan 2, 2025 spouse's 401(k)
Kura Oncology, Inc. SVP, Finance & Accounting Option to purchase common stock 42.5K Jan 2, 2025 Direct

Insider Reports Filed by Thomas Doyle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KURA Kura Oncology, Inc. Jan 2, 2025 3 $0 4 Jan 6, 2025 SVP, Finance & Accounting
KURA Kura Oncology, Inc. Jan 29, 2024 3 -$41.3K 4 Jan 31, 2024 SVP, Finance & Accounting
KURA Kura Oncology, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 SVP, Finance & Accounting
KURA Kura Oncology, Inc. Feb 16, 2023 2 $0 4 Feb 21, 2023 SVP, Finance & Accounting
KURA Kura Oncology, Inc. Jan 27, 2023 2 -$21.5K 4 Jan 31, 2023 SVP, Finance & Accounting
KURA Kura Oncology, Inc. Feb 7, 2022 2 $0 4 Feb 9, 2022 SVP, Finance & Accounting
KURA Kura Oncology, Inc. Feb 7, 2022 0 $0 3 Feb 9, 2022 SVP, Finance & Accounting